Fibers of poly(N-isopropylacrylamide) (PNIPAAm), ethylcellulose (EC) and a blend of both were successfully fabricated by electrospinning. Analogous drug-loaded fibers were prepared loaded with ketoprofen (KET). Scanning and transmission electron microscopy showed that the fibers were largely smooth and cylindrical, with no phase separation observed. The addition of KET to the spinning solutions did not affect the morphology of the resultant fibers, and no drug particles could be observed to separate from the polymer matrix. X-ray diffraction demonstrated that the drug was present in the amorphous physical form in the fiber matrix. There are significant intermolecular interactions between KET and polymers, as evidenced by IR spectroscopy and molecular modelling. Water contact angle measurements proved that the PNIPAAm and PNIPAAm/EC fibers switched from being hydrophilic to hydrophobic when the temperature was increased through the lower critical solution temperature of 32 ºC. In vitro drug release studies found that the PNIPAAm/EC blend nanofibers were able to synergistically combine the properties of the two polymers, giving temperature-sensitive systems with sustained release properties. In addition, they were established to be non-toxic and suitable for cell growth. This study thus demonstrates that electrospun blend PNIPAAm/EC fibers comprise effective and biocompatible materials for drug delivery systems and tissue engineering.
Introduction
Electrospinning comprises a straightforward and cost-effective technique for the fabrication of fibers with dimensions on the nanometer to micron scale. 1, 2 Electrospun nanofibers have attracted considerable attention due to their high surface area to volume ratio, narrow diameters, high porosity and often desirable mechanical properties. [3] [4] [5] [6] [7] [8] They are attractive for a number of practical applications, such as wound dressing, drug delivery, tissue engineering, medical prostheses, textiles, filtration systems, and sensors, inter alia. [9] [10] [11] [12] [13] Responsive polymers exhibit a change in configuration, dimensions, or physicochemical properties following exposure to an external stimulus. This could comprise changes in pH, temperature, electromagnetic field, light or solvent. [14] [15] [16] Poly(N-isopropylacrylamide) (PNIPAAm) is one such polymer, and undergoes a sharp phase transition (from linear to globular) at a lower critical solution temperature (LCST) of ca. 32 ºC in aqueous solution. [17] [18] [19] It has been intensively studied for potential applications in biomedicine. [20] [21] [22] When the temperature is raised from below to above the LCST, PNIPAAm rapidly changes from being hydrophilic to hydrophobic. 23, 24 While attractive for its thermoresponsive properties, PNIPAAm cannot easily be electrospun. Thus, researchers have resorted to the use of copolymers or blends of PNIPAAm with other polymers to aid the spinning process and enhance the quality of the fibers produced. [25] [26] [27] [28] In one such study, Wang and co-workers electrospun blends of PNIPAAm and polystyrene; the resultant nanofibers exhibited reversible superhydrophilicity and superhydrophobicity when the temperature was varied between 20 ºC and 50 ºC. 29 Lin et al. explored PNIPAAm / poly(2-acrylamido-2-methylpropanesulfonic acid) nanofibers, and found that drug release at temperatures below the LCST was faster than when experiments were performed above the LCST. 30 In other work, Song produced PNIPAAm / poly(ethylene oxide) (PEO) composite nanofibers. 31 The fibers were loaded with vitamin B12 as a model hydrophilic drug, and the release profile could be modulated by varying the PEO/PNIPAAm ratio, the release temperature, and the drug loading. In this work, we aimed to expand on these earlier investigations to develop enhanced understanding of the properties of electrospun PNIPAAm blends with other polymers.
Ketoprofen (KET), a non-steroidal anti-inflammatory drug, has been widely used for the treatment of inflammation, pain and rheumatism but suffers from very poor water solubility (0.5 µg/ml). 32 It also has a short biological half-life (1.5 to 2 hours). 33 Commercially it is available as a number of formulations, including ketoconazole and ketolac. The dosing regimen is 50-100 mg twice a day. 32 Therefore, it is desirable to develop controlled release formulations of KET to increase patient convenience and reduce side effects.
In this study, KET was chosen as a model drug for the development of controlled release formulations. It was blended with PNIPAAm and ethylcellulose (EC, an inert, water-insoluble, non-toxic polymer widely used to prepare slow-release formulations)
and electrospun into fibers. 34, 35 By combining these three components, we aimed to produce thermoresponsive sustained release formulations of KET. These could be used to ensure that the drug concentration in the body remains within the therapeutic window for prolonged periods of time, mimizing over-or underdosing and maximizing therapeutic benefit and patient convenience.
Experimental

Materials
N-isopropylacrylamide (NIPAAm) was purchased from Japan TCI (Tokyo, Japan).
Ethyl cellulose (EC, 6-9 m Pa·s) was obtained from the Aladdin Chemistry Co., Ltd.
(Shanghai, China). Ketoprofen (KET) was purchased from the Beijing J&K Scientific 
Synthesis of PNIPAAm
Preparation of electrospinning solutions
PNIPAAm and EC were dissolved in anhydrous ethanol under magnetic stirring for 12 h at room temperature, resulting in clear and homogenous solutions. The total concentration of polymer was 25 % (w/v). KET was added into certain solutions at a drug to polymer ratio of 1:4 (w/w). The viscosity of the electrospinning solutions was measured using a viscometer (CAP 2000+, Brookfield Co. Ltd., USA). Full details of the solutions prepared are listed in Table 1 .
Electrospinning
The electrospinning solution was placed into a 5 mL plastic syringe fitted with a stainless steel needle (internal diameter 0. 
Characterization
The surface morphology of the fibers was analyzed with scanning electron microscopy (SEM; JSM-5600 LV microscope, JEOL, Tokyo, Japan). Samples were Five measurements were recorded for each sample, and the results are reported as mean ± S.D.
Molecular modelling
Molecular mechanics calculations were undertaken using HyperChem version 8.0.10.
The structures of each of the compounds were first drawn using ChemBio Draw Ultra 14.0. A decameric EC or PNIPAAm species was constructed to represent the polymer.
The individual structures were then imported into HyperChem, and models constructed as detailed in previous work. Combinations of the energy minimised polymer-KET structures were then merged to create drug-polymer complexes, and these were subjected to the same minimisation procedures to determine whether they were energetically stabilised in relation to the individual components. This procedure is similar to that previously reported by Dott et al. 
Cell viability experiments
Nanofibers were collected directly onto coverslips by electrospinning. 36 coverslips were placed on the collector and electrospinning performed as detailed in Section 2. Following incubation for 4 h (37 ºC, 5 % CO 2 ), the medium was removed and 400 μL of DMSO added to each well, after which the plates were shaken for 20 min at 37 ºC.
The solution from each well was transferred into a 96-well plate, and then the absorbance measured at a wavelength of 570 nm using a microplate reader (Multiskan FC, Thermo Scientific Instrument Co. Ltd., Shanghai, China). Three independent MTT assays were carried out, with 6 replicates per assay.
Results and discussion
Morphology analysis
Scanning electron microscopy (SEM) images of the fibers are shown in Fig. 1 . The viscosities of the electrospinning solutions are listed in Table 1 . F1, F2, F4, and F5 exhibit some flat ribbon-like fibers, with this being particularly evident for F1 and F4
where PNIPAAm is the sole polymer present and solution viscosity is low (less than 200 cP). Some beads are also observed on the surface of F2 and F5. These fibers are formed from EC solutions for which the viscosity is very high (more than 300 cP).
Combining EC and PNIPAAm results in highly uniform fibers (F3), with no beads visible and no ribbon-like fibers. Similarly regular cylindrical fibers are observed when KET is introduced to the polymer blend (F6, F7, F8). Combining EC and
PNIPAAm thus appears to aid the formation of smooth fibers. The addition of EC to the PNIPAAm solution results in higher viscosity which increases the electrospinnability and aids the formation of smooth fibers. 37 When the viscosity is too high (as is the case with the pure EC solutions), beaded fibers (F2, F5) form because the solution becomes difficult to force through the syringe needle, making the solution flow rate somewhat unstable. 38, 39 The ideal viscosity for this system appears to lie between 200 cP and 300 cP.
Transmission electron microscopy (TEM) images of F3 and F6 are also given in The diameters of the fibers are given in Table 1 
Physical form analysis and component compatibility
X-ray diffraction patterns are given in Fig. 2A The FTIR spectrum for pure ketoprofen shows two distinct peaks: one at 1696 cm -1 representing the stretching vibration of the carbonyl group in the KET dimer, and another at 1655 cm -1 from stretching of the ketone group. The peak at 1696 cm -1 is observed because in its crystalline form KET molecules are bound together in dimers through intermolecular hydrogen bonds. The peak at 1655 cm -1 is present in the spectra of F4, F5 and F6, which indicates the presence of KET in these samples. It is however shifted somewhat: in F4, this peak is merged with the PNIPAAm C=O stretch into a single peak at 1645 cm -1 , and in F5 is moved to 1658 cm -1 . The peak at 1696 cm -1 cannot be seen in the spectra of F4, F5 and F6, indicating the absence of any KET dimers in the fibers. This is consistent with the result of X-ray diffraction analysis, which showed the absence of any crystalline (dimeric) KET.
Molecular modelling
Since KET has C=O groups, EC has -OH groups, and PNIPAAm has NH groups, it is to be expected that there will be H-bonding interactions between KET and EC or KET and PNIPAAm. 37 The shifts in peak positions identified in the IR spectra indicated that such interactions do indeed occur in the fibers; to confirm this, we constructed some simple molecular models of EC, PNIPAAm and KET using the HyperChem software. The structures of an EC or PNIPAAM decamer and KET were first individually optimized, and subsequently appropriate combinations of the energetically minimized structures were merged to create drug-polymer complexes.
The geometric preferences for the energetically minimized EC-PNIPAAm and KET-polymer complexes are depicted in Fig. 3 . The energetic contributions to the overall steric energies are listed in Table 2 .
It is clear from the data in Table 2 
Thermoresponsive behavior
The wettability of the nanofibers was studied as a function of temperature, and the results are depicted in Fig. 4A . The water contact angles of the drug-free and analogous drug-loaded nanofibers are basically identical (F1 cf. F4; F2 cf. F5; F3 cf.
F6
). The addition of KET thus has little influence on the contact angles. The pure EC fibers are hydrophobic regardless of the temperature, with only a very small increase in contact angle seen across the temperature range studied. In contrast, as the temperature is raised from 25 ºC to 45 ºC, the surfaces of the PNIPAAm-containing fibers change abruptly from being hydrophilic to hydrophobic. This occurs as the temperature increases through the LCST between 31 ºC and 33 ºC, and results in a dramatic increase in the contact angle. Fig. 4B shows the proposed mechanism underlying the thermoresponsive properties of the PNIPAAm/EC composite nanofibers. When the temperature is below the LCST (32 ºC), the hydrophilic C=O and N-H groups in the PNIPAAm chains interact easily with water molecules to form intermolecular hydrogen bonds. 43 Although there are hydrophobic EC molecules also present in the blend fibers, the water droplets can presumably minimize their contact with these and maximize their interactions with PNIPAAm units. Consequently, the blend fibers exhibit hydrophilic properties below the PNIPAAm LCST. When the temperature is above the LCST, the formation of intramolecular hydrogen bonds between the C=O and N-H groups in PNIPAAm lead to a collapsed globular conformation of the chains, which makes it very hard for their C=O and N-H groups to interact with water molecules. 29 Therefore, the blend fibers are hydrophobic above the LCST.
Drug release
In vitro KET release profiles of KET from the drug loaded nanofibers are given in Fig.   5 . Considering first the data in Fig. 5A (1:2 PNIPAAm/EC systems), at 25 ºC, the amount of drug release from F4 (PNIPAAm) is highest, followed by F7
(PNIPAAm/EC 1:2 w/w) and F5 (EC). The different drug release profiles may be explained by the fibers' different surface wettability. Drug release from a hydrophilic carrier tends to be faster than that from a hydrophobic material. 30 When the temperature is 25 ºC, the PNIPAAm-containing fibers exhibit hydrophilic properties, while the EC materials are hydrophobic. The fibers comprising only PNIPAAm as the filament-forming polymer are more hydrophilic than the blend fibers, explaining why the latter lies intermediate between the two extremes. At 37 ºC, there is a burst release of roughly 40% of the loaded drug in the first 5 h of the dissolution experiment. Very little further release is seen from F4, while F5 and F6 show slow, sustained, release over ca. 55 h. F6 releases most drug under these conditions, followed by F5 and F4.
The drug release profile from the EC fibers (F5) is very similar at both temperatures investigated. This is because EC is not thermoresponsive, but can be used as a sustained-release drug delivery system. In contrast, the maximum drug release from the PNIPAAm-containing fibers is much greater at 25 ºC than at 37 ºC, as a result of the temperature sensitive properties of PNIPAAm. However, at both temperatures the F4 fibers show a very significant burst release at the start of the experiment. These effects are somewhat reduced for the PNIPAAm/EC F6 samples, indicating that the blend nanofibers combine the advantages of the two polymers, possessing both thermosensitive and sustained release properties. These results thus demonstrate the concept of using PNIPAAm/EC blend fibers for temperature-triggered sustained release.
The influence of the PNIPAAm/EC weight ratios was also explored, and a comparison of F6, F7 and F8 are presented in Fig. 5B . At 25 ºC, the amount of drug released from F7 (PNIPAAm/EC 1:1) is highest, followed by F6 (1:2) and F8 (1:4). At 37 ºC, the opposite trend is seen. These observations indicate that an increased content of EC decreases the drug release rate at 25ºC but increases it at 37ºC. This is to be expected, since PNIPAAm becomes hydrophobic at T > 32 ºC but is hydrophilic below this temperature. Thus, at 25 ºC the hydrophilic nature of the PNIPAAm increases the rate of release, and F7 (which contains most PNIPAAm) releases its KET load most rapidly. At 37 ºC, the hydrophobic nature of the PNIPAAm delays release; thus, the more PNIPAAm present the slower the drug release rate, and F7 releases most slowly under these conditions. The drug release profiles from F8
(PNIPAAm/EC 1:4) are similar at both temperatures investigated; the low PNIPAAm content in this system is presumably insufficient to provide it with significant thermoresponsive properties.
Cell viability
The results of MTT cell viability measurements performed on the fibers are given in ratio, but the release rate from the fibers is rather low at 37 ºC. When the PNIPAAm/EC ratio is raised to 1:4 the materials appear to lose most of their thermoresponsive properties. The blend fibers also proved to be non-toxic and suitable for cell growth. This study thus demonstrates that electrospun blend PNIPAAm/EC fibers can be used as thermoresponsive carriers for the sustained release of poorly water soluble drugs, as well as in tissue engineering.
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